- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03940170
Clinical Effectiveness of(VistaProof)in Comparison With ICDAS-II & Histological Validation for Detecting Occlusal Caries
August 13, 2021 updated by: Mohamed samy El-sayed
Clinical Effectiveness of Quantitative Light Fluorescence Based Device (Vistacam Proof) in Comparison With ICDAS-II and Histological Validation in Detection of Initial Pits and Fissures Caries:: Diagnostic Accuracy Study
a diagnostic accuracy study control trial is to be held to evaluate the Clinical performance of quantitative light fluorescence based device (Vistacam Proof) in comparison with the visual examination and histological validation in detection of initial pits and fissures caries
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- The British University in Egypt
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 50 years (ADULT, CHILD)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Egyptian population
Description
Inclusion Criteria:
- Patients aged from 15 to 50 years.
- Patient at least has one posterior pits and fissure occlusal caries.
- No gender restriction
- Co-operative patients who signed the informed consent.
- Good general health
- Acceptable oral health
Exclusion Criteria:
- Pregnancy.
- Disabilities.
- Systemic disease or severe medical complications.
- Allergic history concerning methacrylate.
- Rampant caries.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
vistacam
|
Light fluorescence device
|
ICDAS II
|
visual examination
|
Fissurotomy
|
Light fluorescence device
visual examination
histological validation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pits and fissure caries
Time Frame: through study completion, an average of 1 year
|
occlusal pits and fissure caries in posterior teeth non-cavitated
|
through study completion, an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2020
Primary Completion (ACTUAL)
May 13, 2021
Study Completion (ACTUAL)
August 9, 2021
Study Registration Dates
First Submitted
April 25, 2019
First Submitted That Met QC Criteria
May 4, 2019
First Posted (ACTUAL)
May 7, 2019
Study Record Updates
Last Update Posted (ACTUAL)
August 19, 2021
Last Update Submitted That Met QC Criteria
August 13, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 2222
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Light Fluorescence Device
-
Amsterdam UMC, location VUmcEnrolling by invitation
-
University College, LondonUniversity College London HospitalsRecruitingFluorescence Guided SurgeryUnited Kingdom
-
The University of QueenslandCompletedAge Related Macular Degeneration | Lutein and Zeaxanthin Dietary Intake | Blue Light Exposure | Electronic Device UseAustralia
-
University of AarhusCompletedFocus of Study is: Near Infrared Fluorescence ImagingDenmark
-
Pusan National University Yangsan HospitalRecruitingBiomarkers | Fluorescence | Cell-Free Nucleic Acids | Palliative ChemotherapyKorea, Republic of
-
Lee's Pharmaceutical LimitedNot yet recruiting5-aminolevulinic Acid | Fluorescence-guided ResectionChina
-
Milton S. Hershey Medical CenterNot yet recruitingSafety Issues | Device Dislodgement | Device Intolerance | Device Ineffective
-
Leiden University Medical CenterErasmus Medical CenterRecruitingPerfusion | Traumatic Injury | Fluorescence ImagingNetherlands
-
Mỹ Đức HospitalHarvard University Faculty of Medicine; The Needleman Lab, Northwest Lab Building... and other collaboratorsRecruitingFrozen Embryo Transfer | IVF/ICSI | Cumulus Cell | Fluorescence Lifetime Imaging MicroscopyVietnam
-
Schulthess KlinikCompletedDevice Success Rate | Device PerformanceSwitzerland, Austria
Clinical Trials on vistacam proof
-
Cairo UniversityCompleted
-
Centre Hospitalier Universitaire de Saint EtienneInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement and other collaboratorsCompleted
-
Proof DiagnosticsICON Clinical Research; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaboratorsCompletedCOVID-19 | Asymptomatic COVID-19United States
-
Pennington Biomedical Research CenterUnited States Department of Agriculture (USDA)Completed
-
Geisinger ClinicCompletedCommunication | Vaccination RefusalUnited States
-
Memorial Sloan Kettering Cancer CenterVanderbilt UniversityActive, not recruitingSolid Tumors | Preoperative Aerobic TrainingUnited States
-
Geisinger ClinicCompleted
-
Geisinger ClinicCompletedHealth Promotion | Wellness ProgramsUnited States
-
Corindus Inc.Completed
-
Theodor Bilharz Research InstituteActive, not recruitingUrinary Bladder Neoplasms | MicrotiaEgypt